Results 171 to 180 of about 41,567 (239)

Efficient Access to New Thienobenzo-1,2,3-Triazolium Salts as Preferred Dual Cholinesterase Inhibitors. [PDF]

Biomolecules
Mlakić M, Sviben M, Ratković A, Raspudić A, Barić D, Šagud I, Lasić Z, Odak I, Škorić I.   +8 more
europepmc   +1 more source

Synthetic strategies and medicinal chemistry perspectives of dual acting carbonic anhydrase modulators with monoamine oxidase and cholinesterase inhibitors. [PDF]

RSC Med Chem
Bindra S, Mostafa EM, Abdelgawad MA, Selim S, Kumar S, Mathew B.   +5 more
europepmc   +1 more source

Neuropsychiatric signs and symptoms of Alzheimer\u27s disease: New treatment paradigms [PDF]

, 2017
et al,, Musiek, Erik
core   +1 more source

Barbiturate-sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies. [PDF]

Future Med Chem
Kassem AF, Omar MA, Temirak A, El-Shiekh RA, Srour AM.   +4 more
europepmc   +1 more source

Longitudinal impact of cholinesterase inhibitors on cholinergic white matter integrity in mild cognitive impairment: A diffusion MRI study. [PDF]

J Alzheimers Dis Rep
Ramezannezhad E, Alzheimer's Disease Neuroimaging Initiative.   +1 more
europepmc   +1 more source

New Charged Cholinesterase Inhibitors: Design, Synthesis, and Characterization. [PDF]

Molecules
Mlakić M, Barić D, Ratković A, Šagud I, Čipor I, Piantanida I, Odak I, Škorić I.   +7 more
europepmc   +1 more source

Potential Azo-8-hydroxyquinoline derivatives as multi-target lead candidates for Alzheimer's disease: An in-depth in silico study of monoamine oxidase and cholinesterase inhibitors. [PDF]

PLoS One
Guerguer FZ, Rossafi B, Abchir O, Raouf YS, Albalushi DB, Samadi A, Chtita S.   +6 more
europepmc   +1 more source

Investigating the Potency of Erythrina‒Derived Flavonoids as Cholinesterase Inhibitors and Free Radical Scavengers Through in silico Approach: Implications for Alzheimer's Disease Therapy. [PDF]

Adv Appl Bioinform Chem
Akili AWR, Thurfah NA, Hardianto A, Latip J, Herlina T.   +4 more
europepmc   +1 more source

Co-Designing a Consult Patient Decision Aid for Continuation Versus Deprescribing Cholinesterase Inhibitors in People Living with Dementia. [PDF]

Drugs Aging
Ailabouni NJ, Thompson W, Hilmer SN, Quirke L, McNeece J, Bourke A, Furst C, Reeve E.   +7 more
europepmc   +1 more source